Revolving door: DEA’s No. 2 quits amid studies of earlier consulting work for Big Pharma
WASHINGTON (AP) — The U.S. Drug Enforcement Administration’s second-in-command has quietly stepped down amid reporting by The Associated Press that he as soon as consulted for a pharmaceutical distributor sanctioned for a deluge of suspicious painkiller shipments and did comparable work for the drugmaker that grew to become the face of the opioid epidemic: Purdue Pharma.
...










